Challenges of Drug Development in L-dopa-Naive Subjects with Diagnosis of Early Parkinson’s Disease

How to overcome hurdles in your early Parkinson's drug development

August 4, 2020 | Tom Babic, MD, PhD

Tom Babic, M.D., Ph.D., presents his 2020 AD/PD session on challenges in early Parkinson’s drug development.

Tom Babic, MD, PhD
MEET THE AUTHOR

Tom Babic, MD, PhD

Vice President, Scientific Solutions, Neuroscience
LEARN MORE